<--- Back to Details
First PageDocument Content
Gilead Sciences / Pharmacology / Organofluorides / Cyclopropanes / Bristol-Myers Squibb / Reverse-transcriptase inhibitor / Emtricitabine / Tenofovir / Efavirenz / Chemistry / Fixed dose combination / Organic chemistry
Date: 2013-07-15 17:15:43
Gilead Sciences
Pharmacology
Organofluorides
Cyclopropanes
Bristol-Myers Squibb
Reverse-transcriptase inhibitor
Emtricitabine
Tenofovir
Efavirenz
Chemistry
Fixed dose combination
Organic chemistry

HIV_CareGuide_2013[removed]FINAL DRAFT.pub

Add to Reading List

Source URL: www.cphcs.ca.gov

Download Document from Source Website

File Size: 151,09 KB

Share Document on Facebook

Similar Documents

A Day in Life at BMS Welcome to A Day in Life at BMS where you will meet leaders from our R&D organization and learn more about research and development at Bristol-Myers Squibb, as well as network with our scientists. To

DocID: 1vrK6 - View Document

NoIN THE Supreme Court of the United States BRISTOL-MYERS SQUIBB COMPANY, PETITIONER,

DocID: 1tuCc - View Document

Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty)

DocID: 1tut4 - View Document

September 2003 USA Bristol-Myers Squibb Medical Imaging

DocID: 1sKnx - View Document

May 2003 Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, Massachusetts 01862

DocID: 1sC8T - View Document